Predicting postacute phase anaemia after aneurysmal subarachnoid haemorrhage: nomogram development and validation.

The developed and validated nomogram can be used to calculate individualised anaemia risk and has the potential to serve as a practical tool for clinicians in devising improved treatment strategies for aSAH.